Daxor Corporation
DXR
$8.00
$0.23012.96%
Weiss Ratings | DXR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | C- | |||
Rating Factors | DXR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Fair | |||
Solvency Index | Good | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | DXR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | -0.05 | |||
Price History | DXR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 3.36% | |||
30-Day Total Return | 0.13% | |||
60-Day Total Return | -10.01% | |||
90-Day Total Return | -11.11% | |||
Year to Date Total Return | 5.96% | |||
1-Year Total Return | 3.09% | |||
2-Year Total Return | -8.57% | |||
3-Year Total Return | -25.58% | |||
5-Year Total Return | -20.40% | |||
52-Week High % Change | -22.30% | |||
52-Week Low % Change | 18.62% | |||
Price | DXR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $10.00 | |||
52-Week Low Price | $6.55 | |||
52-Week Low Price (Date) | Feb 11, 2025 | |||
52-Week High Price (Date) | Dec 02, 2024 | |||
Valuation | DXR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 37.61M | |||
Enterprise Value | 38.34M | |||
Price/Earnings (TTM) | 21.99 | |||
Earnings Per Share (TTM) | 0.35 | |||
Earnings Per Share Growth | -64.50% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 244.34 | |||
Price/Book (Q) | 1.15 | |||
Enterprise Value/Revenue (TTM) | 248.62 | |||
Price | $8.00 | |||
Enterprise Value/EBITDA (TTM) | -- | |||
Enterprise Value/EBIT | -53.07 | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | DXR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 4.84M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | $0.03 | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | $0.03 | |||
Company Info | DXR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | -- | |||
Address | 109 Meco Lane Oak Ridge, TN 37830 | |||
Website | www.daxor.com | |||
Country | United States | |||
Year Founded | 1971 | |||
Profitability | DXR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -468.48% | |||
Profit Margin | 1,094.03% | |||
Management Effectiveness | DXR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -1.39% | |||
Return on Equity | 5.35% | |||
Income Statement | DXR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | -- | |||
Total Revenue (TTM) | 154.20K | |||
Revenue Per Share | $0.03 | |||
Gross Profit (TTM) | 154.20K | |||
EBITDA (TTM) | -- | |||
EBIT (TTM) | -722.40K | |||
Net Income (TTM) | 1.69M | |||
Net Income Avl. to Common (TTM) | 1.69M | |||
Total Revenue Growth (Q YOY) | -11.36% | |||
Earnings Growth (Q YOY) | 46.31% | |||
EPS Diluted (TTM) | 0.35 | |||
EPS Diluted Growth (Q YOY) | 46.83% | |||
Balance Sheet | DXR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | -- | |||
Cash Per Share (Q) | -- | |||
Total Current Assets (Q) | 20.10K | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 32.66M | |||
Current Ratio (Q) | 0.285 | |||
Book Value Per Share (Q) | $6.75 | |||
Total Assets (Q) | 34.38M | |||
Total Current Liabilities (Q) | 70.60K | |||
Total Debt (Q) | 1.65M | |||
Total Liabilities (Q) | 1.72M | |||
Total Common Equity (Q) | 32.66M | |||
Cash Flow | DXR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -- | |||
Cash from Financing (TTM) | 1.68M | |||
Net Change in Cash (TTM) | -- | |||
Levered Free Cash Flow (TTM) | 52.20K | |||
Cash from Operations (TTM) | -1.68M | |||